SRC and colonic neoplasm: Results from our survey of the Src and EGFR-related pathways show a significant decrease in Src phosphorylation (Y418), EGFR phosphorylation (Y845) and the downstream mediator STAT5a/b (Y694 and Y699), both in adjacent normal and colon tumor tissue taken from ETBF treated ApcMin/+ mice that received Anthos treatment.